Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

FRESENIUS KABI USA

  • FDA Approval
  • Sept. 24, 2024, 08:51 UTC
  • 36
  • 0 comments

FDA approve LEVOFLOXACIN

Comment Full text

JUBILANT GENERICS

  • FDA Approval
  • Sept. 24, 2024, 08:51 UTC
  • 46
  • 0 comments

FDA approve LEVOFLOXACIN

Comment Full text

HEC PHARM

  • FDA Approval
  • Sept. 24, 2024, 08:51 UTC
  • 46
  • 0 comments

FDA approve LEVOFLOXACIN

Comment Full text

CIPLA

  • FDA Approval
  • Sept. 24, 2024, 08:51 UTC
  • 50
  • 0 comments

FDA approve DIHYDROERGOTAMINE MESYLATE

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • Sept. 24, 2024, 08:51 UTC
  • 47
  • 0 comments

FDA approve LEVOFLOXACIN

Comment Full text

IVAX SUB TEVA PHARMS

  • FDA Approval
  • Sept. 24, 2024, 08:51 UTC
  • 51
  • 0 comments

FDA approve HYDROCHLOROTHIAZIDE

Comment Full text

SOMERSET THERAPS LLC

  • FDA Approval
  • Sept. 24, 2024, 08:51 UTC
  • 56
  • 0 comments

FDA approve TRAVOPROST

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • Sept. 24, 2024, 08:51 UTC
  • 44
  • 0 comments

FDA approve LEVOFLOXACIN

Comment Full text

NOVITIUM PHARMA

  • FDA Approval
  • Sept. 24, 2024, 08:51 UTC
  • 46
  • 0 comments

FDA approve ATENOLOL; CHLORTHALIDONE

Comment Full text

MSN

  • FDA Approval
  • Sept. 24, 2024, 04:22 UTC
  • 57
  • 0 comments

FDA approve CLOPIDOGREL BISULFATE

Comment Full text
  • Previous
  • 348
  • 349
  • 350
  • 351
  • 352
  • Next

Search

News categories

  • Technical Exchange News(14648)
  • Event(6229)
  • SEC News(390597)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(237936)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin